Author Information
Anna M. Piekarska is a distinguished researcher affiliated with the Department of Infectious Diseases and Hepatology at the Medical University of Łódź, located in Łódź, Poland. Her work is primarily focused on infectious diseases, with significant contributions to understanding and managing viral infections such as HCV, HBV, and COVID-19. Her expertise and research have played a crucial role in advancing the field of infectious diseases, particularly in the context of viral hepatitis and COVID-19 management.Research Contributions
Anna M. Piekarska has made substantial contributions to the field of infectious diseases, with a particular focus on viral infections. Her research includes studies on the treatment and management of HCV and HIV co-infections, the impact of kidney failure on COVID-19 severity, and the effectiveness of treatments like Tocilizumab for severe COVID-19 cases. Her work has also addressed the challenges posed by breakthrough COVID-19 cases during the Delta variant's dominance and offered recommendations for managing SARS-CoV-2 infections. Additionally, she has explored the stability of antiviral treatments and their impact on diabetes incidence among HCV patients.Aliases
Anna M. Piekarska is also known by several aliases, including Anna Piekarska, A. Piekarska, A Piekarska, and Anna M. Piekarska. These variations of her name are used interchangeably across different publications and platforms.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
1847 |
| h-index |
21 |
| Paper Count |
180 |
